RxDoctor Payments Data

Lauren Rufener, APRN

Family · Wooster, OHNPI 1811458300

Payments from drug & device makers

$2,573in general payments, 2019–2025

Across 131 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$522
  • GSK$356
  • United Therapeutics Corporation$296
  • Jazz Pharmaceuticals Inc.$202
  • Sanofi$197
  • Boehringer Ingelheim$130
  • plus $869 from 20 others

What the payments were for

  • Food & beverage$2,38793%
  • Education$1867%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,573 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$1,518
Medicare patients
12
Services billed
21

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter94$85,615
Breo ElliptaFluticasone/Vilanterol91$47,953
Arnuity ElliptaFluticasone Furoate56$15,973
DuleraMometasone/Formoterol19$7,760
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate21$4,585
Fluticasone-SalmeterolFluticasone Propion/Salmeterol21$2,725
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,526
Albuterol Sulfate HfaAlbuterol Sulfate51$1,195
Mirtazapine38$718
Modafinil31$709
Ropinirole Hcl48$674
Roflumilast16$583
Ipratropium Bromide20$439
Methylphenidate Hcl28$401
Montelukast Sodium68$366

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$356$149,542241 claims
MerckDulera$30$7,76019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.

Other family in Wooster

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →